Clinical trial

CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology

NCT03940846

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention Virtual biopsy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2019-03-01

PhaseN/A

Conditions

Nonsmall Cell Lung Cancerverified · MONDO: tumor suppressor gene on chromosome 11

Interventions

Virtual biopsyDIAGNOSTIC_TEST

Sponsors & collaborators

Maastricht Universitylead sponsor

University of California, San Franciscocollaborator

Radboud University Medical Centercollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03940846 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.